Use of a percutaneous left ventricular assist device for high-risk cardiac interventions and cardiogenic shock

Journal of Invasive Cardiology

Volumn 22, Issue 8, 2010, Pages 360-364

  Thomas, Joseph L ^a,b   Al Ameri, Hazim ^a   Economides, Christina ^a,b   Shareghi, Shahrzad ^a,b   Abad, Damian Grovas ^a   Mayeda, Guy ^a   Burstein, Steven ^a   Shavelle, David M ^a,b,c  

^a GOOD SAMARITAN HOSPITAL   (United States)

^b HARBOR UCLA MEDICAL CENTER   (United States)

^c UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; AORTA STENOSIS; ARTICLE; BLOOD TRANSFUSION; CARDIAC PATIENT; CARDIOGENIC SHOCK; CARDIOMYOPATHY; CARDIOVASCULAR PROCEDURES; CLINICAL ARTICLE; CORONARY ARTERY OBSTRUCTION; CORONARY HEMODYNAMICS; DYING; FEMALE; FUNCTIONAL STATUS; HEART ANEURYSM; HEART ASSIST DEVICE; HEART DEATH; HEART EJECTION FRACTION; HEART FAILURE; HIGH RISK PATIENT; HOSPITAL DISCHARGE; HUMAN; INTERVENTIONAL CARDIOVASCULAR PROCEDURE; MALE; MITRAL VALVE PROLAPSE; MITRAL VALVE REGURGITATION; MULTIPLE ORGAN FAILURE; MYOCARDITIS; PERCUTANEOUS CORONARY INTERVENTION; PERCUTANEOUS LEFT VENTRICULAR ASSIST DEVICE; SURVIVAL RATE;

AGED; AGED, 80 AND OVER; AORTIC VALVE STENOSIS; CARDIOMYOPATHIES; FEMALE; FOLLOW-UP STUDIES; HEART DISEASES; HEART-ASSIST DEVICES; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; MYOCARDITIS; RETROSPECTIVE STUDIES; RISK FACTORS; SEVERITY OF ILLNESS INDEX; SHOCK, CARDIOGENIC; TREATMENT OUTCOME;

EID: 77957045497     PISSN: 10423931     EISSN: 15572501     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Santa-Cruz RA, Cohen MG, Ohman EM. Aortic counterpulsation: A review of the hemodynamic effects and indications for use. Catheter Cardiovasc Interv 2006;67:68-77.
2. Thiele H, Sick P, Boudriot E, et al. Randomized comparison of intra-aortic balloon support with a percutaneous left ventricular assist device in patients with revascularized acute myocardial infarction complicated by cardiogenic shock. Eur Heart J 2005;26:1276-1283.
3. Thiele H, Smalling RW, Schuler GC. Percutaneous left ventricular assist devices in acute myocardial infarction complicated by cardiogenic shock. Eur Heart J 2007;28:2057-2063.
4. Thiele H, Lauer B, Hambrecht R, et al. Reversal of cardiogenic shock by percutaneous left atrial-to-femoral artery bypass assistance. Circulation 2001;104:2917-2922.
5. CardiacAssist Inc., press release. August 4, 2008. Available at http://www.cardiacassist. com/downloadfiles/PressReleases/ Four%20New%20Centers%20July%202008.pdf
6. Seyfarth M, Sibbing D, Bauer I, et al. A randomized clinical trial to evaluate the safety and efficacy of a percutaneous left ventricular assist device versus intra-aortic balloon pumping for treatment of cardiogenic shock caused by myocardial infarction. J Am Coll Cardiol 2008;52:1584-1588.
7. Dixon SR, Henriques JP, Mauri L, et al. A prospective feasibility trial investigating the use of the Impella 2.5 system in patients undergoing high-risk percutaneous coronary intervention (The PROTECT I trial): Initial U.S. experience. JACC Cardiovasc Interv 2009;2:91-96.
8. Burkhoff D, Cohen H, Brunckhorst C, O'Neill WW, for the TandemHeart Investigators Group. A randomized multicenter clinical study to evaluate the safety and efficacy of the TandemHeart percutaneous ventricular assist device versus conventional therapy with intraaortic balloon pumping for treatment of cardiogenic shock. Am Heart J 2006;152:469,e1-e8.
9. EuroSCORE calculator available at http://www.euroscore.org/calc.html
10. Lee WA, Brown MP, Nelson PR, et al. Percutaneous access for endovascular aortic aneurysm repair ("Preclose" technique). J Vasc Surg 2007;45:1095-1101.
11. Rajdev S, Krishnan P, Irani A, et al. Clinical application of prophylactic percutaneous left ventricular assist device (TandemHeart) in high-risk percutaneous coronary intervention using an arterial preclosure technique: Single-center experience. J Invasive Cardiol 2008;20:67-72.
12. Rajdev S, Irani A, Sharma S, Kini A. Clinical utility of TandemHeart for high-risk procedures: Percutaneous balloon aortic valvuloplasty followed by complex PCI. J Invasive Cardiol 2007;19:e346-e349.
13. Aragon J, Lee MS, Kar S, Makkar RR. Percutaneous left ventricular assist device: "TandemHeart" for high-risk coronary intervention. Catheter Cardiovasc Interv 2005;65:346-352.
14. Al-Husami W, Yturralde F, Mohanty G, et al. Single-center experience with the TandemHeart percutaneous ventricular assist device to support patients undergoing high-risk percutaneous coronary intervention. J Invasive Cardiol 2008;20:319-322.
15. Kar B, Forrester M, Gemmato C, et al. Use of the TandemHeart percutaneous ventricular assist device to support patients undergoing high-risk percutaneous coronary intervention. J Invasive Cardiol 2006;18:A6.
16. Giombolini C, Notaristefano S, Santucci S, et al. Percutaneous left ventricular assist device, TandemHeart, for high risk percutaneous coronary revascularization. A single centre experience. Acute Card Care 2006;8:35-40.
17. Vranckx P, Foley DP, de Feijter PF, et al. Clinical introduction of the Tandemheart, a percutaneous left ventricular assist device, for circulatory support during high risk percutaneous coronary intervention. Int J Cardiovasc Intervent 2003;5:35-39.
18. Gimelli G, Wolff MR. Hemodynamically supported percutaneous coronary revascularization improves left ventricular function in patients with ischemic dilated cardiomyopathy at very high risk for surgery: A single-center experience. J Invasive Cardiol 2008;20:642-646.
19. Vranckx P, Meliga E, De Jaegere PP, et al. The TandemHeart, percutaneous transeptal left ventricular assist device: A safeguard in high-risk percutaneous coronary interventions. The six-year Rotterdam experience. EuroIntervention 2008;4:331-337.
20. Nashef SAM, Roques F, Michel P, et al. for the EuroSCORE study group. European system for cardiac operative risk evaluation (EuroSCORE). Eur J Cardio-Thoracic Surg 1999;16:9-13.
21. Geissler HJ, Holzl P, Marohl S, et al. Risk stratification in heart surgery: Comparison of six scoring systems. Eur J Cardio-Thoracic Surg 2000;17:400-406.
22. Smith SC et al. ACC/AHA/SCAI 2005 Guideline Update for Percutaneous Coronary Intervention - Summary article: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation 2006;113:156-1155
23. Motivala AA, Tamhane U, Saab F, et al. Temporal trends in antiplatelet/antithrombotic use in acute coronary syndromes and in-hospital major bleeding complications. Am J Cardiol 2007;100:1359-1363.
24. Feit F, Voeltz MD, Attubato MJ, et al. Predictors and impact of major hemorrhage on mortality following percutaneous coronary intervention from the REPLACE-2 Trial. Am J Cardiol 2007;100:1364-1369.
25. Brugts JJ, Mercado N, Hu S, et al. Relation of periprocedural bleeding complications and long-term outcome in patients undergoing percutaneous coronary revascularization (from the evaluation of oral xemilofiban in controlling thrombotic events [EXCITE] Trial. Am J Cardiol 2009;103:917-922.